Insmed Statistics

Total Valuation

Insmed has a market cap or net worth of $22.41 billion. The enterprise value is $21.93 billion.

Market Cap	22.41B
Enterprise Value	21.93B

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, before market open.

Earnings Date	Aug 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Insmed has 216.75 million shares outstanding. The number of shares has increased by 20.64% in one year.

Current Share Class	216.75M
Shares Outstanding	216.75M
Shares Change (YoY)	+20.64%
Shares Change (QoQ)	+0.86%
Owned by Insiders (%)	0.72%
Owned by Institutions (%)	94.94%
Float	198.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	27.34
Forward PS	11.66
PB Ratio	31.76
P/TBV Ratio	45.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	26.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.47, with a Debt / Equity ratio of 1.05.

Current Ratio	4.47
Quick Ratio	3.88
Debt / Equity	1.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-11.73

Financial Efficiency

Return on equity (ROE) is -294.46% and return on invested capital (ROIC) is -42.30%.

Return on Equity (ROE)	-294.46%
Return on Assets (ROA)	-31.11%
Return on Invested Capital (ROIC)	-42.30%
Return on Capital Employed (ROCE)	-56.29%
Weighted Average Cost of Capital (WACC)	8.51%
Revenue Per Employee	$492,526
Profits Per Employee	-$711,391
Employee Count	1,664
Asset Turnover	0.42
Inventory Turnover	1.28

Taxes

In the past 12 months, Insmed has paid $5.58 million in taxes.

Income Tax	5.58M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.40% in the last 52 weeks. The beta is 0.77, so Insmed's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	-1.40%
50-Day Moving Average	114.32
200-Day Moving Average	152.52
Relative Strength Index (RSI)	48.42
Average Volume (20 Days)	5,184,016

Short Selling Information

The latest short interest is 19.13 million, so 8.83% of the outstanding shares have been sold short.

Short Interest	19.13M
Short Previous Month	17.61M
Short % of Shares Out	8.83%
Short % of Float	9.65%
Short Ratio (days to cover)	4.67

Income Statement

In the last 12 months, Insmed had revenue of $819.56 million and -$1.18 billion in losses. Loss per share was -$5.70.

Revenue	819.56M
Gross Profit	670.48M
Operating Income	-965.22M
Pretax Income	-1.18B
Net Income	-1.18B
EBITDA	-949.04M
EBIT	-965.22M
Loss Per Share	-$5.70

Full Income Statement

Balance Sheet

The company has $1.22 billion in cash and $742.46 million in debt, giving a net cash position of $481.05 million or $2.22 per share.

Cash & Cash Equivalents	1.22B
Total Debt	742.46M
Net Cash	481.05M
Net Cash Per Share	$2.22
Equity (Book Value)	704.85M
Book Value Per Share	3.26
Working Capital	1.25B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$895.66 million and capital expenditures -$25.97 million, giving a free cash flow of -$921.64 million.

Operating Cash Flow	-895.66M
Capital Expenditures	-25.97M
Depreciation & Amortization	16.18M
Net Borrowing	-5.02M
Free Cash Flow	-921.64M
FCF Per Share	-$4.25

Full Cash Flow Statement

Margins

Gross margin is 81.81%, with operating and profit margins of -117.77% and -144.44%.

Gross Margin	81.81%
Operating Margin	-117.77%
Pretax Margin	-143.76%
Profit Margin	-144.44%
EBITDA Margin	-115.80%
EBIT Margin	-117.77%
FCF Margin	n/a

Dividends & Yields

Insmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.64%
Shareholder Yield	-20.64%
Earnings Yield	-5.28%
FCF Yield	-4.11%

Dividend Details

Analyst Forecast

The average price target for Insmed is $197.05, which is 90.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$197.05
Price Target Difference	90.61%
Analyst Consensus	Strong Buy
Analyst Count	22
Revenue Growth Forecast (3Y)	83.54%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 3, 2011. It was a reverse split with a ratio of 1:10.

Last Split Date	Mar 3, 2011
Split Type	Reverse
Split Ratio	1:10

Scores

Insmed has an Altman Z-Score of 7.82 and a Piotroski F-Score of 4.

Altman Z-Score	7.82
Piotroski F-Score	4